NCT04518163 is a NA clinical trial of Tranexamic Acid in Placenta Previa, sponsored by Aswan University Hospital.

Who is sponsoring NCT04518163?

NCT04518163 is sponsored by Aswan University Hospital.

What drugs are being tested in NCT04518163?

Interventions in NCT04518163: Tranexamic Acid, placebo to TA, Bakri Balloon.

What condition does NCT04518163 study?

NCT04518163 studies Placenta Previa.

Is NCT04518163 still recruiting?

NCT04518163 is currently status unknown. Last updated 21 September 2020.

Last reviewed 2020-09-21 · How we verify

NCT04518163

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bakri Balloon Plus Tranexamic Acid During Cesarean Delivery for Placenta Previa

Status unknown NA Last updated 21 September 2020

What this trial tests

NA trial testing Tranexamic Acid in Placenta Previa in 140 participants. Status unknown.

Timeline

1 September 2020

Primary endpoint
30 June 2022

31 July 2022

Quick facts

Lead sponsor	Aswan University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	140
Start date	1 September 2020
Primary completion	30 June 2022
Estimated completion	31 July 2022
Sites	1 location across Egypt

Drugs / interventions tested

Tranexamic Acid (Tranexamic Acid) — full drug profile →
placebo to TA — full drug profile →
Bakri Balloon

Conditions studied

Placenta Previa — all drugs for Placenta Previa →

Sponsor

Aswan University Hospital

Who can join

Adults 18 to 45, female only, with Placenta Previa. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective to investigate the effect of adjunctive intravenous tranexamic acid (TA) on blood loss during cesarean section (CS) in patients with placenta previa undergone Bakri balloon tamponade

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine.
Vlaar APJ, Dionne JC, de Bruin S, Wijnberge M, et al · · 2021 · cited 65× · PMID 34677620 · DOI 10.1007/s00134-021-06531-x

Verify or expand the search:

Other trials of Tranexamic Acid

Trials testing the same drug.

NCT07501884 — REDUCER Trial (TXA in Urethroplasty) · Phase 4 · not yet recruiting
NCT07460518 — Tranexamic Acid for Bleeding Reduction During TURP Surgery · Phase 4 · not yet recruiting
NCT07390799 — Prophylactic Tranexamic Acid in Low-Risk Repeat Cesarean Delivery: A Randomized Controlled Trial · NA · not yet recruiting
NCT07078942 — Prophylactic Intravenous Tranexamic Acid on Perioperative Blood Loss in Pregnant Women Undergoing Cesarean Section · Phase 4 · not yet recruiting
NCT07263841 — Comparison of Effectiveness of Tranexamic Acid Mesotherapy Versus Glutathione Mesotherapy in Post Burn Facial Hyperpigme · Phase 2 · active not recruiting

Other recruiting trials for Placenta Previa

Currently open trials in the same condition.

NCT07025954 — Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta · NA · recruiting
NCT06849349 — EXAMINATION OF SOME MOLECULES IN PLACENTAS OF PATIENTS WITH PLACENTA PREVIA, PLACENTA PERCREATA · recruiting
NCT06867874 — Syncytiotrophoblast-derived Extracellular Vesicles in Placenta Previa and Accreta Spectrum · NA · recruiting

Other Aswan University Hospital trials

Trials by the same sponsor.

NCT06491394 — Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats · Phase 4 · completed
NCT06211088 — Famotidine Versus Placebo in Emergency Pediatric Surgery As a Risk to Postoperative Nausea and Vomiting · NA · completed
NCT06583590 — Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction · Phase 2, PHASE3 · recruiting
NCT06537323 — Femoral Nerve Block, Periarticular Nerve Group (PENG) Block, and Preoperative IV Fentanyl · NA · recruiting
NCT06535256 — Compare Intraperitoneal Instillation of Bupivacaine+dexmedetomidine Versus Bupivacaine+dexamethasone on Postoperative Pa · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04518163 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aswan University Hospital
Last refreshed: 21 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04518163.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing